-
Randomized controlled pilot trial of extended-release buprenorphine vs. sublingual buprenorphine-naloxone in rural settings (RXR): Study rationale and design.
Mooney LJ, Saxon AJ, Black M, Ober AJ, Lewis M, Walker R, McCormack J, Scheele C, Hser Y. Randomized controlled pilot trial of extended-release buprenorphine vs. sublingual buprenorphine-naloxone in rural settings (RXR): Study rationale and design. Contemporary Clinical Trials 2026;108288 (in press).
-
The association between sleep disturbance and stimulant use: A cross-lagged examination.
Horigian VE, Schmidt RD, Feaster DJ, Duan R, Gonzalez ST, Hefner K, Shmueli-Blumberg D, Vena A, Moran LM, DiCamillo CA, Shafazand S, Tross S, Feinberg J. The association between sleep disturbance and stimulant use: A cross-lagged examination. Addiction 2026 (in press).
-
Perspectives on clinical champions implementing hospital-based opioid treatment in US hospitals.
Peng L, Goff A, Patten A, Bazzi AR, King C, Siegler T, Weinstein Z, Shearer R, Hagedorn H, Oot E, Bart G, Ghitza UE, Englander H. Perspectives on clinical champions implementing hospital-based opioid treatment in US hospitals. JAMA Network Open 2026;9(3):e260446.
-
Patient impressions of opioid-related printouts, discussions and care in a primary care clinical decision support system implementation trial.
Rossom RC, Haapal J, Olson AW, Solberg L, Romagnoli K, Wright E, Crain AL, Borgert-Spaniol C, Gorodisher J, Tusing L, Allen C, McCormack J, Bart G, Miley K, Hooker SA. Patient impressions of opioid-related printouts, discussions and care in a primary care clinical decision support system implementation trial. Proceedings of the 596h Hawaii International Conference on Science Systems 2026.
-
Primary care clinicians’ perspectives on an electronic health record-integrated clinical decision support tool for opioid use disorder.
Barg G, Borgert-Spaniol CM, Crain AL, Haapala JL, O'Connor PJ, Hooker SA, Solberg LI, Miley KM, Wright EA, Tusing LD, Olson AW, Allen CI, McCormack JM, Hefner K, Rossom RC. Primary care clinicians' perspectives on an electronic health record-integrated clinical decision support tool for opioid use disorder. Journal of Substance Use and Addiction Treatment 2026 (in press).
-
Extended-release vs sublingual buprenorphine in pregnancy through 12 months post partum: A randomized clinical trial.
Winhusen TJ, Lofwall MR, Kropp F, Lewis D, Smid MC, Young JL, Hodgkins C, Krans EE, Hansen Z, Wachman EM, Schiff DM, Guille C, Rudolf V, Chowdhury T, Leeman L, Lewis M, Matthews AG, Cochran G, King J, Wilder C, Rosa C. Extended-release vs sublingual buprenorphine in pregnancy through 12 months post partum: A randomized clinical trial. JAMA Internal Medicine 2026 (in press).
-
Brief report: Meth, tranq, gas station heroin & other drugs complicating addiction treatment.
Winstanley EL, Liebschutz JM, Murray-Krezan C, Switzer GE, Nash S, Kawasaki S. Brief report: Meth, tranq, gas station heroin & other drugs complicating addiction treatment. American Journal on Addiction 2026 (in press).
-
External validation of Epic’s risk of opioid abuse and overdose model among primary care patients in three health systems.
Hooker SA, Rossom RC, Haapala J, Crain L, Miley K, Olson AW, Kane S, Christensen K, O'Connor PJ, Bart G, Wright EA. External validation of Epic's risk of opioid abuse and overdose model among primary care patients in three health systems. Journal of General Internal Medicine 2026 (in press).
-
Emergency department-initiated buprenorphine for opioid use disorder: A randomized clinical trial.
D'Onofrio G, Herring AA, Hawk KF, Perrone J, Cowan E, McCormack RP, Dziura J, Matthews AG, Pantalon MV, Owens P, Martel S, Coupet Jr. E, Lofwall MR, Walsh SL, Edelman EJ, Carpenter JE, Strout TD, Baumann MR, Anderson E, Barrett TW, Dorey A, Taillac P, Cochran G, Crandall CS, Wilson J, Manteuffel J, Cole JB, Whiteside LK, Jones C, Samuels E, Huntley K, Fiellin DA. Emergency department-initiated buprenorphine for opioid use disorder: A randomized clinical trial. JAMA 2026 (in press).
-
Investigator- and site-level outcomes of participation in an ED-based clinical trial [commentary].
Carpenter JE, Hawk KF, Herring A, Cowan E, McCormack R, Owens PH, Martel SH, Edelman EJ, Huntley K, Perrone J, D'Onofrio G. Investigator- and site-level outcomes of participation in an ED-based clinical trial [commentary]. JAMA Network Open 2026;9(2):e2555847.